Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Argentina

MNCs Forced To Invest In Batch Testing

May 2006 | FDI Alert

A number of leading R&D-based multinationals in Argentina are increasingly obliged to invest in quality control laboratories in order to comply with local red tape. The national drug regulator, ANMAT, obliges foreign firms to carry out fresh tests on all batches of imported products, and refuses to recognise US or EU certification.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Growing Resentment On Price Controls

Companies / Argentina Argentine pharmaceutical industry associations CAEME, CILFA and CPERALA have insisted that member companies have not significantly raised prices since the introduction of anti-inflation controls late...
November 2006
Homegrown Drugmakers Win New Export Markets

Companies / Argentina Drugmakers in Argentina are entering new export markets as far afield as Yemen and Singapore, helping to reduce reliance on traditional markets in Latin America. The region still accounted for 70% of...
November 2006
Argentina To Fine Sanofi-Aventis

Companies / Argentina Argentine consumer watchdog CNDC has fined French drug major Sanofi-Aventis ARS0.83mn (US$0.27mn) for failing to notify finance ministry officials of merger plans in 2003. The acquisition of Aventis...
May 2006
Argentine Drugmakers Plead For Special Treatment

Companies / Argentina Argentine indigenous drug manufacturers' association CILFA has called on the country's government to improve incentives for the sector. Local firms including market leader Roemmers have recently expressed...
April 2006
Argentina Sees Strong Local Drug Market, Weak Exports

Companies / Argentina Argentine statistics office INDEC estimates that total sales by Argentina's indigenous drug firms grew 5.4% in 2005 at manufacturer prices. Local sources have pointed to further data indicating that...
April 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS